Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 12

Showing 12 citing articles:

Antigen Specificity: A Fluctuating Aspect in the Development of Clinical Antibodies?
Sandeep Sherawat, Suraj H. Shinde, Abhay H. Pande
Apmis (2025) Vol. 133, Iss. 1
Closed Access
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
Sheila M. Keating, Brett W. Higgins
Antiviral Research (2024) Vol. 227, pp. 105902-105902
Closed Access | Times Cited: 3
Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews
Xinglong Liu, Zhengfeng Li, Xiao Li, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Bending the Curve Through Innovations to Overcome Persistent Obstacles in HIV Prevention and Treatment
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of AIDS and HIV Treatment (2024) Vol. 6, Iss. 1, pp. 44-53
Open Access | Times Cited: 2
Strengthening Global Health Resilience: Marburg Virus-Like Particle Vaccines and the One Health Approach
Ram Bahadur Khadka, Khimdhoj Karki, Jitendra Kumar Pandey, et al.
Science in One Health (2024) Vol. 3, pp. 100076-100076
Open Access | Times Cited: 1
Nanoluciferase Reporter Zika Viruses as Tools for Assessing Infection Kinetics and Antibody Potency
Yanqun Xu, Devin Vertrees, Yong He, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2190-2190
Open Access | Times Cited: 3
Therapeutic proteins have the potential to become new weapons in the fight against antibiotic resistance
Mohamed Reda Halawa, Maxwell Akantibila, Briana E. Reid, et al.
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 3
Dry powder formulations of hyperimmune serum
Annalisa Bianchera, Gaetano Donofrío, Fabio Sonvico, et al.
Drug Delivery and Translational Research (2024)
Open Access
Comparison of immunoglobulin Y antibody production in new and spent laying hens
Pornphimon Metheenukul, Win Surachetpong, Noppadol Prasertsincharoen, et al.
Veterinary World (2024), pp. 2177-2184
Open Access
Non-Traditional Antibacterial Therapeutic: Focus on Safety, Manufacturing, and Regulatory Dynamics
Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar, et al.
(2024), pp. 787-810
Closed Access
Human antibodies neutralizing the alpha-latrotoxin of the European black widow
Maximilian Ruschig, Jana Nerlich, Marlies Becker, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Page 1

Scroll to top